Close Menu
Tamar BridgeTamar Bridge
  • Home
  • Latest News
  • About Us
    • Our Team
    • Join the team
  • Policies
    • Cookies
    • Terms & Conditions
    • Privacy Policy
  • Sitemap
  • —————–
  • Money
  • Tech
  • Lifestyle
  • News
  • Health
  • Property
  • Business
  • Travel
  • Motors
  • Contact Us
Facebook X (Twitter) LinkedIn
Facebook X (Twitter)
Tamar BridgeTamar Bridge
Contact
  • About Us
    • Our Team
    • Contact Us
    • Join the team
  • News
  • Culture
  • Money
  • Business
  • Health
  • Lifestyle
  • Tech
  • Motors
Tamar BridgeTamar Bridge
Home»News»Kvantify Unveils Groundbreaking Drug Discovery Method
Kvantify CEO & Co-Founder, Hans Henrik Knudsen (PRNewsfoto/Kvantify ApS)
News

Kvantify Unveils Groundbreaking Drug Discovery Method

Sam AllcockBy Sam Allcock12/10/20243 Mins Read

Kvantify has announced the launch of a revolutionary computational method designed to accelerate the early phases of drug discovery. This innovative approach is a significant enhancement to the company’s existing computational drug discovery platform, Koffee, and distinguishes itself from other solutions currently available in the market.

According to Hans Henrik Knudsen, CEO of Kvantify, the new binding affinity tool stands out in performance, boasting benchmark tests that reveal it is 100 times faster than comparable state-of-the-art methods while maintaining the same level of accuracy. This tool plays a crucial role in drug discovery, as binding affinity refers to the strength of interaction between a drug and its target protein. A molecule must establish a strong interaction with a biological target to elicit a therapeutic effect, making binding affinity calculations essential in the drug development process.

In drug design, the range of possible molecular variations and modifications is virtually limitless, highlighting the need for rapid and precise calculations. Knudsen emphasised the importance of Kvantify’s new method: “Matching our speed with high accuracy gives us the option to push accurate physics-based binding affinity calculations further up the drug discovery pipeline.”

One of the standout features of Kvantify’s binding affinity method is its efficiency, significantly reducing calculation times to just a few minutes. This quick turnaround enables researchers to explore a broader range of molecular options without being hindered by lengthy computational processes.

Additionally, Kvantify’s Koffee binding affinity method offers several advantages over traditional approaches. Unlike many existing solutions, it does not require manual setup or parameterisation, which can often complicate the drug discovery process. Furthermore, being fully physics-based, it eliminates the need for training data, a common requirement in machine learning and AI-based methods. This characteristic ensures that researchers can rely on the accuracy and robustness of the calculations without the inherent biases that can arise from training datasets.

Kvantify’s advancements come at a pivotal time in the pharmaceutical industry, where the demand for faster and more efficient drug discovery processes is growing. By harnessing cutting-edge computational methods, Kvantify aims to streamline the development of new therapeutics and enhance the overall efficacy of drug discovery pipelines.

As the industry continues to grapple with the complexities of drug development, Kvantify’s innovative approach promises to simplify the process while delivering high-quality results. This commitment to improving drug discovery methodologies reflects the company’s broader mission to revolutionise the way therapeutics are developed and brought to market.

In conclusion, Kvantify’s newly launched computational method not only marks a significant step forward in the field of drug discovery but also positions the company as a leader in leveraging technology to enhance pharmaceutical research. As they continue to refine their tools and platforms, the potential for faster and more effective drug development becomes increasingly attainable, promising benefits for patients and healthcare providers alike.

discovery drug groundbreaking kvantify method news unveils
Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
Previous ArticleKier Group Plc Share Chat – Chat About KIE Shares – ADVFN
Next Article RSM US and RSM UK Plan Transatlantic Merger

Other stories that may interest you

How to Appear Younger at 40: The No-Nonsense Guide for Men in the UK

16/06/2025

How Understanding the Business Strategy of Online Casinos Makes You a Better Player

12/06/2025

How to handle difficult sellers: a guide for UK estate agents

11/06/2025

Latest Stories

Experts Reveal How Your Sunglasses Could Land You a £5,000 Fine While Driving

24/06/2025

Stop wasting money at the airport: travel experts reveal the add ons that are ACTUALLY worth it 

24/06/2025

How has the rise of online casinos affected land-based casinos?

23/06/2025

Deputy Prime Minister Angela Rayner visits HC-One’s Daisy Nook House Care Home in Ashton-under-Lyne

23/06/2025
  • Facebook
  • Twitter
  • LinkedIn
Sections
  • News
  • Culture
  • Money
  • Business
  • Health
  • Lifestyle
  • Tech
  • Motors

Tamar Bridge News is your trusted guide through the currents of UK news, committed to bridging the gap between information and insight with clarity, precision, and a human-centric approach.

Company

  • Home
  • Latest News
  • About Us
  • Our Team
  • Contact Us
  • Join the team
  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions
  • Sitemap

Latest Stories

Experts Reveal How Your Sunglasses Could Land You a £5,000 Fine While Driving

By Lucy Contrino

Stop wasting money at the airport: travel experts reveal the add ons that are ACTUALLY worth it 

By Lucy Contrino

How has the rise of online casinos affected land-based casinos?

By Sam Allcock
© 2025 Tamar Bridge News | All rights reserved

Type above and press Enter to search. Press Esc to cancel.